Nanotechnology got a big boost last year when the federal government launched its National Nanotechnology Initiative, which will provide almost $520 million in funding in fiscal year 2002. As part of that initiative, the National Science Foundation is now funding six new applications-oriented nanotech centers.
“These centers will give the field of nanotechnology high visibility,” says Richard W. Siegel, who will direct one of the centers, located at Rensselaer Polytechnic Institute. “They will become magnets for people entering the field.” Many of the new research units will be housed at already existing nanotech centers. But while those nanotech institutions are oriented toward understanding the fundamental scientific principles governing the field, each of the new centers will focus on specific applications of nanotech in areas such as electronics and medicine (see table). Industrial partners like IBM and DuPont will help bring new technology to market.
The new center at Northwestern University, for instance, hopes to churn out highly sophisticated sensors by exploiting a technique for “writing” dense patterns of biological molecules on solid surfaces (see “Nanotech Goes to Work,” TR January/February 2001). According to Chad Mirkin, director of the university’s Institute of Nanotechnology, the patterned surfaces could lead to new kinds of detection systems for discovering drugs or diagnosing diseases. By supporting highly targeted efforts like these, the new centers hope to bring researchers one step closer to transforming nanoscience into real technology.
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.